Antigen-specific therapies for the treatment of multiple sclerosis: A clinical trial update

Expert Opinion on Investigational Drugs

Volumn 6, Issue 11, 1997, Pages 1715-1727

  Spack, E G ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Altered peptide ligand; Anergy; Antigen specific therapy; Apoptosis; Bystander suppression; Multiple sclerosis

Indexed keywords

AUTOANTIGEN; GLATIRAMER; LIGAND; MYELIN BASIC PROTEIN; MYELIN PROTEIN; PEPTIDE; VACCINE;

APOPTOSIS; CEREBROSPINAL FLUID; CLINICAL TRIAL; ETIOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0030696916     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.11.1715     Document Type: Review

References (75)